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Bank voles in Poland are reservoirs of zoonotic viruses. 
To determine seroprevalence of hantavirus, arenavirus, 
and cowpox virus and factors affecting seroprevalence, we 
screened for antibodies against these viruses over 9 years. 
Cowpox virus was most prevalent and affected by extrinsic 
and intrinsic factors. Long-term and multisite surveillance 
is crucial.
The most prevalent rodentborne zoonotic viruses in Eu-rope are hantaviruses, lymphocytic choriomeningitis 
virus (LCMV), cowpox virus (CPXV), and Puumala virus 
(PUUV) (1). In 2016, a total of 18 countries in Europe re-
ported 2,190 cases of hantavirus disease, mainly caused by 
PUUV. The occurrence of rodentborne viruses in Poland 
is not well documented. The first outbreak of hantavirus 
infections among humans (9 cases) was reported in 2007. 
During 2012–2016, a total of 79 cases of hantavirus infec-
tions were reported in Poland, 55 of them in Podkarpackie 
Province in 2014 (2). In 2015, a case of human cowpox 
infection was reported in Poland (3).
We conducted a multisite, long-term study of hanta-
virus and arenavirus seroprevalence in northeastern Po-
land. Our objectives were to monitor seroprevalence of 
LCMV, CPVX, and PUUV in 3 populations of bank voles 
(Myodes glareolus) from ecologically similar but dispa-
rate sites in northeastern Poland and to analyze intrinsic 
(host sex, host age) and extrinsic (study year, study sites) 
factors that might affect seroprevalence among these ro-
dent populations.
Study sites were located in the Mazury Lake District 
region in northeastern Poland (Appendix Figure 1, https://
wwwnc.cdc.gov/EID/article/25/8/19-0217-App1.pdf). The 
sites and methods used for trapping rodents and sampling 
and processing trapped animals have been described (4). 
We analyzed serum samples by using an immunofluores-
cence assay (IFA) (Appendix Figure 2). We diluted serum 
samples 1:10 in phosphate-buffered saline and tested their 
reactivity to hantaviruses by using a PUUV IFA, to cowpox 
viruses by using a CPXV IFA, and to arenaviruses by us-
ing an LCMV IFA (5). IFAs were conducted as previously 
described (6,7). The statistical approach has been compre-
hensively documented (4).
We tested 652 bank voles and detected antibodies 
against all 3 viruses. Overall seroprevalence of combined 
viral infections was 25.9% (95% CI 23.0%–29.1%), but 
most infections were attributable to CPXV (seropreva-
lence 25% [95% CI 22.1%–28.2%]). Only 2 voles were 
LCMV seropositive (0.3% [95% CI 0.2%–0.9%]), and only 
5 were PUUV seropositive (0.76% [95% CI 0.4%–1.6%]). 
We therefore confined further analyses to CPXV.
The effect of study year on CPXV seroprevalence (by 
χ2/d.f.) was highly significant (χ22 31.2; p<0.001); seroprev-
alence was 2.7 times higher among bank voles sampled in 1These authors contributed equally to this article.
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2010 (36.1% [95% CI 31.7%–40.7%]) than in 2002 (13.1% 
[7.4%–21.0%]). CPXV seroprevalence also varied marked-
ly among voles from the 3 study sites (χ22 46.84; p<0.001); 
seroprevalence was highest among voles from Urwitałt 
(38.4% [95% CI 33.9%–43.1%]) and lower among voles 
from Tałty (23.0% [19.3%–27.2%]) and Pilchy (10.3% 
[95% CI 5.7%–17.4%]). CPXV seroprevalence was also 
significantly affected by the sex of the host (χ21 10.1; p = 
0.001) and was 1.5 times higher for male than female voles 
(Figure, panel A). Seroprevalence increased with host age 
(χ22 12.73; p = 0.002) and was lowest among voles from age 
class 1 (immature) (16.0% [95% CI 10.0%–24.1%]) and 
higher among those from age class 2 (mostly young adults) 
(27.2% [95% CI 23.2%–31.5%]) and age class 3 (breeding 
older adults) (30.1% [95% CI 25.9%–34.6%]).
The differences in seroprevalence between sites were 
also confounded by interaction with study year (year × site 
× presence/absence of antibodies against CPXV; χ2
4
 12.76; 
p = 0.012). Seroprevalence increased significantly at all 3 
study sites from 2006 to 2010 and was highest in Urwitałt 
(0.83-fold). The largest seroprevalence increases from 
2006 to 2010 were in Tałty (2.35-fold) and Pilchy (2.9-
fold) (Figure, panel B).
The pattern of age-related changes in seroprevalence 
also differed between study sites (site × age × presence/ab-
sence of antibodies against CPXV; χ2
4
 = 17.45; p = 0.002) 
(Figure, panel C). In Urwitałt, the overall seroprevalence 
was highest among voles in age class 2 (44.5% [95% CI 
37.5%–51.8%]), 1.57-fold lower among voles in age class 1, 
and 1.22-fold lower among voles in age class 3. In Tałty and 
Pilchy, seroprevalence was highest among voles from age 
class 3. In Tałty, seroprevalence was 1.8-fold higher among 
voles in age class 3 compared with voles in other age classes. 
In Pilchy, seroprevalence among voles in age class 3 was 
10.8-fold higher than among voles in age class 2.
Our data show that CPXV was the dominant viral 
pathogen among bank voles in Poland during the study 
period, although PUUV and LCMV were also found. Our 
finding that the highest seroprevalence was among bank 
voles from Urwitałt complements our previous reports on 
other pathogens, reflects the importance of extrinsic effects 
on prevalence, and establishes that the sites from which 
host populations are sampled is the most influential factor 
affecting prevalence (4).
Our results provide additional information about the 
role of bank voles in Poland as infectious virus reservoirs. 
Although short-term cross-sectional studies are useful as a 
starting point (8), to obtain a comprehensive ecologic pic-
ture, long-term monitoring (several years and preferably 
a decade or longer) and a multisite approach are crucial. 
Identifying rodent species that can serve as reservoirs for 
zoonotic disease viruses and predicting regions where new 
outbreaks are most likely to happen are crucial steps for 
preventing and minimizing the extent of zoonotic disease 
among humans (9).
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Figure. Seroprevalence of cowpoxvirus (CPXV) in bank voles in Poland, 2002–2010. A) By sex; B) by study site location and year of 
study; C) by study site location and vole age class (class 1—immature juvenile bank voles; class 2—mostly young adult bank voles; and 
class 3—breeding older animals). Error bars indicate 95% CI.
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Evidence of spinal cord involvement in Powassan virus in-
fection is largely limited to mouse models. We report a case 
of a polio-like illness caused by Powassan virus infection in 
a 62-year-old man in Canada. Magnetic resonance imag-
ing showed T2 hyperintensities in the anterior horns of the 
cervical spinal cord.
Powassan virus (POWV) is a tickborne flavivirus, named after Powassan, Ontario, Canada, the location of the 
first documented human infection in 1958 (1). Since then, 
≈150 cases of POWV infection have been reported glob-
ally, and incidence has increased over time. A total of 125 
POWV cases have been identified since 2008, 33 (26%) in 
2017 (2). In Canada, most reported POWV infections have 
been in the Great Lakes region. A small number of cases 
have been reported in the Maritime provinces (3). 
POWV is transmitted by members of the Ixodes genus 
of ticks, including I. cookei and the more opportunistic and 
aggressive I. scapularis. POWV has 2 lineages; lineage 2 
(deer tick virus) has emerged quickly in parts of North Amer-
ica, along with the expanding range of I. scapularis ticks.
POWV infection typically begins with prodromal 
symptoms including fever, nausea, headache, and myalgia. 
Central nervous system involvement includes an altered 
level of consciousness, paralysis, or ophthalmoplegia (4). 
POWV encephalitis has a 10% mortality rate, and <50% 
of survivors suffer residual deficits (5). Studies with mice 
have demonstrated that POWV can affect motor neurons 
in the anterior horns of the spinal cord (6). These same 
neurons are affected by poliovirus, West Nile virus, and 
enterovirus D68 (7). However, POWV infection with cord 
involvement in humans is not well documented; 1 human 
case demonstrated motor neuron pathology after POWV 
lineage 2 infection (8), and a second case with suspected 
motor neuronopathy was reported in 2018 (9).
We present the case of a 62-year-old man living in 
urban Ontario who experienced nausea, vomiting, and 
abdominal pain while vacationing in rural Newfoundland. 
He sought treatment at a hospital in Nova Scotia and expe-
rienced diplopia and ataxia. A computed tomography scan 
of the head did not show any acute intracranial event.
The patient became febrile and experienced dysar-
thria, weakness, and respiratory distress. Cerebrospinal 
fluid analysis showed pleocytosis (159 × 106 total nucle-
ated cells: 42% neutrophils, 43% lymphocytes) and el-
evated protein levels (0.79 g/L). He was started on em-
piric treatment with ceftriaxone, ampicillin, acyclovir, 
and dexamethasone. Results of tests for Cryptococcus, 
HIV, syphilis, Lyme disease, herpes simplex viruses 1 and 
2, varicella zoster virus, and acid-fast bacilli were nega-
tive. Initial arbovirus serology results were negative. The 
patient worsened, requiring intubation and transfer to an 
intensive care unit.1These first authors contributed equally to this article.
